Abstract
Mesenchymal stem cells (MSCs) are a promising candidate for cellular therapies. Co-transplantation of MSCs and hematopoietic stem cells (HSCs) promotes successful engraftment and improves hematopoietic recovery. In this study, the effects of co-transplantation of HSCs and mouse bone marrow (BM)-derived MSCs overexpressing CXCR4 (CXCR4-MSC) on CXCR4-MSC homing capacity and the reconstitution potential in lethally irradiated mice were evaluated. Recovery of donor-derived peripheral blood leukocytes and platelets was accelerated when CXCR4-MSCs were co-transplanted with BM cells. The frequency of c-kit+Sca+Lin− HSCs was higher in recipient BM following co-transplantation of CXCR4-MSCs compared with the EGFP-MSC control and the BMT only groups. Surprisingly, the rate of early engraftment of donor-derived BM cells in recipients co-transplanted with CXCR4-MSCs was slightly lower than in the absence of MSCs on day 7. Moreover, co-transplantation of CXCR4-MSCs regulated the balance of T helper cells subsets. Hematopoietic tissue reconstitution was evaluated by histopathological analysis of BM and spleen. Co-transplantation of CXCR4-MSCs was shown to promote the recovery of hematopoietic organs. These findings indicate that co-transplantation of CXCR4-MSCs promotes the early phase of hematopoietic recovery and sustained hematopoiesis.
Similar content being viewed by others
References
Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8, 726–736.
Tolar, J., Le Blanc, K., Keating, A., & Blazar, B. R. (2010). Concise review: Hitting the right spot with mesenchymal stromal cells. Stem Cells, 28, 1446–1455.
Nauta, A. J., & Fibbe, W. E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood, 110, 3499–3506.
Nombela-Arrieta, C., Ritz, J., & Silberstein, L. E. (2011). The elusive nature and function of mesenchymal stem cells. Nature Reviews Molecular Cell Biology, 12, 126–131.
Auletta, J. J., Cooke, K. R., Solchaga, L. A., Deans, R. J., & van’t Hof, W. (2010). Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: Current impact and future directions. Biol Blood Marrow Transplant, 16, 891–906.
Sordi, V. (2009). Mesenchymal stem cell homing capacity. Transplantation, 87, S42–S45.
Karp, J. M., & Leng Teo, G. S. (2009). Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell, 4, 206–216.
Krampera, M. (2011). Mesenchymal stromal cell ‘licensing’: A multistep process. Leukemia, 25, 1408–1414.
Kahn, J., Byk, T., Jansson-Sjostrand, L., Petit, I., Shivtiel, S., Nagler, A., et al. (2004). Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood, 103, 2942–2949.
Brenner, S., Whiting-Theobald, N., Kawai, T., Linton, G. F., Rudikoff, A. G., Choi, U., et al. (2004). CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells, 22, 1128–1133.
Wynn, R. F., Hart, C. A., Corradi-Perini, C., O’Neill, L., Evans, C. A., Wraith, J. E., et al. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 104, 2643–2645.
Rombouts, W. J., & Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia, 17, 160–170.
Arthur, A., Rychkov, G., Shi, S., Koblar, S. A., & Gronthos, S. (2008). Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells, 26, 1787–1795.
Cho, S. W., Sun, H. J., Yang, J. Y., Jung, J. Y., An, J. H., Cho, H. Y., et al. (2009). Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Molecular Therapy, 17, 1979–1987.
Zhang, D., Fan, G. C., Zhou, X., Zhao, T., Pasha, Z., Xu, M., et al. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 44, 281–292.
Chen, W., Li, M., Li, Z., Yan, Z., Cheng, H., Pan, B., et al. (2012). CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunology Letters, 143(2), 161–169.
Chen, W., Li, M., Cheng, H., Yan, Z., Cao, J., Pan, B., et al. (2013). Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells. Cell Biochemistry and Biophysics, 67(3), 1181–1191.
Challen, G. A., Boles, N., Lin, K. K., & Goodell, M. A. (2009). Mouse hematopoietic stem cell identification and analysis. Cytometry A, 75, 14–24.
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., et al. (1999). Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science, 283, 845–848.
Sordi, V., Malosio, M. L., Marchesi, F., Mercalli, A., Melzi, R., Giordano, T., et al. (2005). Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood, 106, 419–427.
Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., et al. (2007). Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica, 92, 897–904.
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., et al. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Medicine, 3, 1337–1345.
Camargo, F. D., Chambers, S. M., Drew, E., McNagny, K. M., & Goodell, M. A. (2006). Hematopoietic stem cells do not engraft with absolute efficiencies. Blood, 107, 501–507.
Osawa, M., Hanada, K., Hamada, H., & Nakauchi, H. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science, 273, 242–245.
Waller, E. K., Ship, A. M., Mittelstaedt, S., Murray, T. W., Carter, R., Kakhniashvili, I., et al. (1999). Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease. Blood, 94, 3222–3233.
Lu, X., Liu, T., Gu, L., Huang, C., Zhu, H., Meng, W., et al. (2009). Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets. Transplant Immunology, 22, 55–61.
Eljaafari, A., Tartelin, M. L., Aissaoui, H., Chevrel, G., Osta, B., Lavocat, F., & Miossec, P. (2012). Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: Contribution to the chronicity of rheumatoid arthritis. Arthritis and Rheumatism, 64, 2147–2157.
Li, F. R., Wang, X. G., Deng, C. Y., Qi, H., Ren, L. L., & Zhou, H. X. (2010). Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clinical and Experimental Immunology, 161, 357–363.
Ezquer, F., Ezquer, M., Contador, D., Ricca, M., Simon, V., & Conget, P. (2012). The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells, 30, 1664–1674.
Acknowledgments
The authors acknowledge CuiPing Zhang, GuoLiang Song, and Chong Chen for technical assistance. This manuscript was proofread by a native English professional with science background at Elixigen Corporation. This work was supported by grants from the National Natural Science Foundation of China (No. 81300441), Jiangsu province LiuDaRenCaiGaoFeng project (2013-WSN-080) and Xuzhou Science and Technology Project, China (No. XZZD1138).
Author information
Authors and Affiliations
Corresponding author
Additional information
Wei Chen, Miao Li, and Guizhen Su have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, W., Li, M., Su, G. et al. Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis. Cell Biochem Biophys 71, 1579–1587 (2015). https://doi.org/10.1007/s12013-014-0381-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0381-y